(Q40857948)

24 September 2017

1 reference

title

Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials (English)

1 reference

Peer Carsten Tfelt-Hansen

24 September 2017

1 reference

series ordinal

1

object named as

P Tfelt-Hansen

1 reference

PubMed ID

8397070

24 September 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

24 September 2017

1 reference

24 September 2017

13

1 reference

24 September 2017

238-244

1 reference

24 September 2017

4

1 reference

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

24 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

5-HT1-like receptor agonists and the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Preclinical Studies on the Anti-Migraine Drug, Sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

From serotonin receptor classification to the antimigraine drug sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Sumatriptan injection is superior to placebo in the acute treatment of migraine--with regard to both efficacy and general well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Sumatriptan in the Treatment of Acute Migraine With Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

The safety and tolerability of sumatriptan: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Coronary vasospasm induced by subcutaneous sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Cardiorespiratory distress after sumatriptan given by injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Transmural myocardial infarction with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Headache recurrence after subcutaneous sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

Oral sumatriptan in acute migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1993.1304238.X

10.1046/J.1468-2982.1993.1304238.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8397070